Primary peritoneal cancer: study of 14 cases and comparison with epithelial ovarian cancer

被引:0
|
作者
Fukuda, T. [1 ]
Imai, K. [1 ]
Yamauchi, M. [1 ]
Teramae, M. [1 ]
Hashiguchi, Y. [1 ]
Ichimura, T. [1 ]
Yasui, T. [1 ]
Sumi, T. [1 ]
机构
[1] Osaka City Univ, Grad Sch Med, Dept Obstet & Gynecol, Abeno Ku, Osaka 5458585, Japan
关键词
Primary peritoneal cancer; Epithelial ovarian cancer; Cytoreductive surgery; Platinum-containing chemotherapy; PAPILLARY SEROUS CARCINOMA; SURFACE; ADENOCARCINOMA; WOMEN;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose of investigation: Primary peritoneal carcinoma (PPC) is histologically similar to ovarian serous carcinoma, but its biochemical features remain obscure. The authors investigated and compared clinical findings, treatments, and outcomes of patients with PPS and those with epithelial ovarian cancer (EOC) patients. Materials and Methods: The authors retrospectively reviewed data from 14 patients with PPC and 219 patients with EOC treated at the present hospital from January 2005 to December 2012, including demographic data, pathologic findings, treatments, and outcomes. Results: Patients with PPC were significantly older (62.6 +/- 8.4 years) than those with EOC (56.3 +/- 11.3 years) (p = 0.045). There was no significant difference in serum CA-125 levels. The five-year survival rates did not differ significantly between patients with PPC (61.1%) and those with EOC (60.3%; p = 0.78); nor between patients with PPC and those with Stage III serous EOC (43.8%; p = 0.40). Conclusions: Treatment strategies for EOC applied to PPC apparently led to similar survival patterns among the two patient groups. Cytoreductive surgery combined with pre/postoperative platinum-containing chemotherapy may be effective for PPC patients.
引用
收藏
页码:49 / 53
页数:5
相关论文
共 50 条
  • [1] Second primary cancer after primary peritoneal, epithelial ovarian, and fallopian tubal cancer: a retrospective study
    Lim, Myong Cheol
    Won, Young-Joo
    Lim, Jiwon
    Salehi, Tahereh
    Yoo, Chong Woo
    Bristow, Robert E.
    BMC CANCER, 2018, 18
  • [2] Second primary cancer after primary peritoneal, epithelial ovarian, and fallopian tubal cancer: a retrospective study
    Myong Cheol Lim
    Young-Joo Won
    Jiwon Lim
    Tahereh Salehi
    Chong Woo Yoo
    Robert E. Bristow
    BMC Cancer, 18
  • [3] SECOND PRIMARY CANCER AFTER PRIMARY PERITONEAL, EPITHELIAL OVARIAN, FALLOPIAN TUBAL CANCER
    Lim, M. C.
    Lim, J.
    Salehi, T.
    Young-Joo, L.
    Yoo, C. W.
    Bristow, R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 754 - 754
  • [4] Chemotherapy for epithelial ovarian, fallopian tube and primary peritoneal cancer
    Webber, Kate
    Friedlander, Michael
    BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY, 2017, 41 : 126 - 138
  • [5] Sorafenib as a third line therapy in patients with epithelial ovarian cancer or primary peritoneal cancer: A phase II study
    Bodnar, Lubomir
    Gornas, Maria
    Szczylik, Cezary
    GYNECOLOGIC ONCOLOGY, 2011, 123 (01) : 33 - 36
  • [6] Phase I study of abagovomab in patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer
    Sabbatini, Paul
    Dupont, Jakob
    Aghajanian, Carol
    Derosa, Felicia
    Poynor, Elizabeth
    Anderson, Sybil
    Hensley, Martee
    Livingston, Phillip
    Lasonos, Alexia
    Spriggs, David
    McGuire, William
    Reinartz, Silke
    Schneider, Sally
    Grande, Cathy
    Lele, Shashikant
    Rodabaugh, Kerry
    Kepner, James
    Ferrone, Soldano
    Odunsi, Kunle
    CLINICAL CANCER RESEARCH, 2006, 12 (18) : 5503 - 5510
  • [7] EFFECTIVENESS OF ORAL ETOPOSIDE IN RECURRENT OR REFRACTORY EPITHELIAL OVARIAN CANCER, PRIMARY PERITONEAL CANCER AND FALLOPIAN TUBE CANCER
    Kongsawatvorakul, C.
    Charakorn, C.
    Chittithaworn, S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 742 - 742
  • [8] Effectiveness of oral etoposide in recurrent or refractory epithelial ovarian cancer, primary peritoneal cancer and fallopian tube cancer
    Kongsawatvorakul, Chompunoot
    Charakorn, Chuenkamon
    Chittithaworn, Suwicha
    Lertkhachonsuk, Arb-Aroon
    JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2022, 42 (06) : 2331 - 2335
  • [9] Niraparib for the Treatment of Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
    Kerliu, Lloreta
    Myruski, Samantha
    Bhatti, Afeefa
    Soni, Priyal
    Petrosius, Paulius
    Pervanas, Helen C.
    Horton, Evan R.
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (10) : 1010 - 1015
  • [10] Epothilones in epithelial ovarian, fallopian tube, or primary peritoneal cancer: a systematic review
    Zagouri, Flora
    Sergentanis, Theodoros N.
    Chrysikos, Dimosthenis
    Dimopoulos, Meletios-Athanassios
    Bamias, Aristotle
    ONCOTARGETS AND THERAPY, 2015, 8 : 2187 - 2198